NCT04578691

Brief Summary

The research project is testing whether in screw insertion of spine surgery using "Anatase" Spine Surgery Navigation System is at least as safe and accurate as using O-arm assisted spine surgery- Medtronic Stealthstation S7 Treatment Guidance System.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 29, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 20, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 8, 2020

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 3, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2022

Completed
Last Updated

November 10, 2022

Status Verified

November 1, 2022

Enrollment Period

1.9 years

First QC Date

August 20, 2020

Last Update Submit

November 9, 2022

Conditions

Keywords

Pedicle screw placement surgery10th thoracic vertebra to 1st sacrum

Outcome Measures

Primary Outcomes (1)

  • Rate of screw outside the vertebral body

    Rate of screw outside the vertebral body as measure by post CT image which perform not later than discharge.

    not later than discharge, up to 14 days

Secondary Outcomes (9)

  • Difference between the actual and virtual (navigation image) of screw's sharp point position

    not later than discharge, up to 14 days

  • Difference between the actual and virtual (navigation image) angle of screws

    not later than discharge, up to 14 days

  • Blood loss during surgery (mL)

    operation 1 day

  • Total intraoperative radiation exposure for the operator and patient

    1 day, the TLD badges will be detected

  • Mean time required for preparation of screw placement (min)

    operation 1 day

  • +4 more secondary outcomes

Study Arms (2)

"Anatase" Spine Surgery Navigation System

EXPERIMENTAL

Using "Anatase" Spine Surgery Navigation System in pedicle screw placement in spine surgery

Device: "Anatase" Spine Surgery Navigation System

Medtronic Stealthstation S7 Treatment Guidance System

ACTIVE COMPARATOR

Using Medtronic Stealthstation S7 Treatment Guidance System in pedicle screw placement in spine surgery

Device: Medtronic Stealthstation S7 Treatment Guidance System

Interventions

using navigation system in pedicle screw placement in spine surgery

"Anatase" Spine Surgery Navigation System

using navigation system in pedicle screw placement in spine surgery

Medtronic Stealthstation S7 Treatment Guidance System

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who need to undergo pedicle screw placement surgery with indication of spinal tumor, traumatic injury or degenerative spine disease.
  • Pedicle screws placed from 10th thoracic vertebra to first sacrum.
  • Age ≥20 years and ≤80 years.
  • Body Mass Index (BMI) \< 40 kg/m2.
  • Spine T-Score by Dual Energy X-ray Absorptiometry ≥ -2.5, 60 days prior to surgery.
  • The subject is willing and able to comply with the procedure and requirements of this trial.
  • The participant is able to understand and provide informed consent, and has signed their written informed consent in accordance with IRB requirements.

You may not qualify if:

  • Pregnant women.
  • Hereditary or acquired haemorrhagic diathesis or coagulation factor deficiency.
  • Be on uncontrolled Diabetes mellitus.
  • Any history of stroke within the previous 6 months.
  • Any history or current evidence suggestive of Coronary Artery Disease or Cerebral Vascular Accident within the previous 6 months, including clinical, EKG, laboratory, or imaging findings.
  • Any terminal illness such that the patient would not be expected to survive more than 6 months.
  • Creutzfeldt-Jakob disease.
  • Known allergy to stainless steel (device material).
  • Have a systematic or local infection, which may increase study risk.
  • Immunocompromised such as but not limited to Acquired Immunodeficiency Syndrome (AIDS), HIV infection, Severe Combined Immunodeficiency Syndrome, Thymic Hypoplasia.
  • Immunologically suppressed, or has received systemic steroids, excluding nasal steroids, at any dose daily for \> 1 month within last 12 months.
  • Any condition that, in the judgment of the investigator, could impose hazards to the patient if study therapy is initiated or affect the participation of the patient in the study.
  • Former spinal surgery may interfere with the present trial.
  • Any condition that increases anesthesia risk.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taipei Veterans General Hospital

Taipei, Taiwan

Location

MeSH Terms

Conditions

Spinal Cord NeoplasmsSpinal Injuries

Condition Hierarchy (Ancestors)

Central Nervous System NeoplasmsNervous System NeoplasmsNeoplasms by SiteNeoplasmsSpinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesBack InjuriesWounds and Injuries

Study Officials

  • Tsung-Hsi Tu

    Taipei Veterans General Hospital, Taiwan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 20, 2020

First Posted

October 8, 2020

Study Start

June 29, 2020

Primary Completion

June 3, 2022

Study Completion

August 31, 2022

Last Updated

November 10, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations